biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > True Story

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 24, 2023 11:36am

85 Views

Post# 35242406

RE:RE:RE:RE:RE:True Story

Yes, everybody has lost money, Craig, just as I have. At least I considered both sides of the story. Anybody who thinks I am the cause of their losses ought to seek legal advice. Their lawyers will help them understand whether I lied and purposefully tried to damage others.

About you trying to characterize what I say about xB3-001 or anything else, your opinion is influence by hate, which is a bad influence when you don't really know what you're talking about anyway.

Stew in your juices, Craig.

Fester.

Hope your head doesn't explode.

JD

<< Previous

Bullboard Posts

Next >>

Three micro-cap stocks on an upswing worth riding